Investors

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

Document Details

Form

Filing Date

Mar 16, 2023

Document Date

Mar 7, 2023

Form Description

Initial filing by director officer or owner of more than ten percent.

Filing Group

3,4,5

Company

Homology Medicines, Inc.

Issuer

Homology Medicines, Inc.

Filer

JORDAN JULIE

Filing Formats

View HTML

MENU